Literature DB >> 1309621

Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.

R H Schwinger1, M Böhm, E Erdmann.   

Abstract

Isometric force of contraction (DT), peak rate of tension increase (+T), peak rate of tension decrease (-T), time to peak tension (TPT), and time to half-relaxation (T 1/2 T) were measured in electrically driven human papillary muscle strips (New York Heart Association [NYHA] class IV heart transplants, dilated cardiomyopathy; nonfailing (NF) donor hearts, brain dead) (1 Hz, 37 degrees C) under basal conditions (1.8 mmol/L Ca2+) and after stimulation with isoprenaline, ouabain, and Ca2+. There was no difference in the isometric contraction (+T, -T, TPT, and T 1/2 T) between NYHA IV hearts and NF hearts under basal conditions. Inotropic stimulation above 300% of basal DT increased -T significantly more in NF hearts (p less than 0.05) compared with NYHA IV hearts. The effectiveness of ouabain and Ca2+ to increase DT was not significantly changed in NYHA IV hearts compared with NF hearts. The isoprenaline-mediated increase in DT was reduced (p less than 0.05) in NYHA IV hearts to a similar extent (70%) as beta-adrenoceptors were downregulated. When the rate of stimulation was increased to 3 Hz (force-frequency relationship), force of contraction increased only in NF preparations, whereas it decreased in NYHA IV myocardium (p less than 0.05). It was concluded that the contractile apparatus in terminally failing human myocardium is sufficient to maximally increase DT. During inotropic stimulation, abnormalities in diastolic rather than systolic contraction become evident. This may indicate abnormal intracellular Ca2+ handling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309621     DOI: 10.1016/0002-8703(92)90755-k

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Pathophysiology of heart failure.

Authors:  E Erdmann
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

2.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

3.  Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts.

Authors:  S E Harding; L A Brown; F del Monte; C H Davies; P O'Gara; G Vescovo; D G Wynne; P A Poole-Wilson
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

4.  Differential effects of tert-butyl-benzohydroquinone, a putative SR Ca2+ pump inhibitor, on isometric relaxation during the staircase in the rabbit and rat ventricle.

Authors:  S Baudet; A Khammari; J Noireaud; H Le Marec
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.

Authors:  M Flesch; R H Schwinger; P Schnabel; F Schiffer; I van Gelder; U Bavendiek; M Südkamp; F Kuhn-Regnier; M Böhm
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

6.  Altered inotropism in the failing human myocardium.

Authors:  U Bavendiek; K Brixius; K Frank; H Reuter; M Pietsch; A Gross; J Müller-Ehmsen; E Erdmann; R H Schwinger
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

7.  EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.

Authors:  R Uhlmann; R H Schwinger; I Lues; E Erdmann
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

8.  Force-frequency-relation in human atrial and ventricular myocardium.

Authors:  R H Schwinger; M Böhm; A Koch; R Uhlmann; P Uberfuhr; E Kreuzer; B Reichart; E Erdmann
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

9.  The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.

Authors:  C Pott; K Brixius; A Bundkirchen; B Bölck; W Bloch; D Steinritz; U Mehlhorn; R H G Schwinger
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

10.  Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.

Authors:  Klara Brixius; Annette Wollmer; Birgit Bölck; Uwe Mehlhorn; Robert H G Schwinger
Journal:  Pflugers Arch       Date:  2003-10-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.